Jonathan D. Root is Director & 10% Owner at eFFECTOR Therapeutics, Inc. (EFTR). They have made 24 open-market trades across 10 companies since 2006, most recently 2026-07-05.
CIK 0001225480
7 open-market purchases totalling $16.8M since 2013, against 17 sales. Across 7 scored buys the stock is up 6.3% at ninety days, and 7.2 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 43% | 43% | 29% |
| Avg Move | -6.4% | +1.1% | +6.3% |
| Alpha | -7.7% | +0.5% | +7.2% |
| Scored | 7 | 7 | 7 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 73% | 64% | 100% |
| Avg Move | -10.3% | -0.2% | -24.4% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CARL | BUY | 2025-07-24 | 2025-07-24 | $15.00 | $7.0M | -16.7% | -2.4% | -5.5% |
| EFTR | SELL | 2022-07-25 | 2022-07-27 | $0.89 | $43K | -0.1% | -30.4% | -34.9% |
| EFTR | SELL | 2021-12-02 | 2021-12-06 | $5.68 | $46K | -6.5% | +1.6% | -43.3% |
| EFTR | SELL | 2021-11-29 | 2021-12-01 | $6.57 | $936K | +16.3% | +41.8% | -24.1% |
| EFTR | SELL | 2021-11-23 | 2021-11-26 | $7.35 | $781K | +2.8% | +31.9% | -25.9% |
| EFTR | SELL | 2021-11-18 | 2021-11-22 | $8.12 | $802K | -25.0% | +13.9% | -28.9% |
| EFTR | SELL | 2021-11-15 | 2021-11-17 | $9.33 | $388K | -27.8% | -19.0% | -49.4% |
| EFTR | SELL | 2021-11-09 | 2021-11-12 | $10.48 | $1.5M | -28.1% | -33.6% | -53.1% |
| EWTX | BUY | 2021-03-30 | 2021-03-31 | $16.00 | $250K | -8.9% | -6.4% | -27.5% |
| SBTX | BUY | 2021-03-03 | 2022-03-18 | $15.25 | $36K | -15.1% | -23.5% | -4.0% |
| SBTX | BUY | 2020-12-08 | 2020-12-08 | $21.00 | $2.0M | +0.7% | +27.7% | +47.3% |
| NARI | BUY | 2020-06-22 | 2022-03-18 | $85.02 | $28K | +6.5% | +2.1% | -32.4% |
| NARI | BUY | 2020-05-27 | 2020-05-27 | $19.00 | $4.8M | +20.5% | +10.6% | +66.5% |
| OMED | SELL | 2017-05-24 | 2017-05-26 | $3.71 | $51K | -4.0% | -3.5% | +18.1% |
| OMED | SELL | 2017-05-19 | 2017-05-22 | $3.70 | $28K | -4.1% | +3.3% | +17.3% |
| OMED | SELL | 2017-05-16 | 2017-05-18 | $3.58 | $25K | -11.2% | +1.4% | +13.4% |
| OMED | SELL | 2014-12-18 | 2014-12-19 | $21.05 | $275K | -32.1% | -0.5% | -0.5% |
| OMED | SELL | 2014-06-09 | 2014-06-11 | $24.57 | $321K | -32.1% | -0.5% | -0.5% |
| OMED | BUY | 2013-07-23 | 2013-07-23 | $17.00 | $2.7M | -32.1% | -0.5% | -0.5% |
| MXL | SELL | 2010-11-29 | 2010-11-30 | $10.54 | $47K | +4.6% | -1.7% | -1.7% |
| MLNX | SELL | 2007-08-17 | 2007-08-21 | $16.16 | $203K | -0.1% | -2.0% | -2.0% |
| OCNW | SELL | 2007-02-23 | 2007-02-23 | $13.79 | $8K | N/A | N/A | N/A |
| OCNW | SELL | 2006-11-07 | 2006-11-08 | $13.23 | $8.1M | N/A | N/A | N/A |
| ATRC | SELL | 2006-08-10 | 2006-08-11 | $5.80 | $501K | -16.7% | -4.1% | -4.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| OMDA |
| 191,877 |
| $3.4M |
| ATRC | 12,041 | $676K |
| EFTR | 133,414 | $24K |
| SBTX | 2,364 | $14K |
| OMED | 6,358 | $6K |
| OCNW | 538 | — |
| Total | $349.1M |
Shares reported on the most recent Form 4, priced at the 2026-07-07 close. 1 holding could not be priced and is excluded from the total.
| Scored | 11 | 11 | 11 |